Cerebral blood volume ASPECTS is the best predictor of clinical outcome in acute ischemic stroke: A retrospective, combined semi-quantitative and quantitative assessment by Padroni, Marina et al.
RESEARCH ARTICLE
Cerebral Blood Volume ASPECTS Is the Best
Predictor of Clinical Outcome in Acute Ischemic
Stroke: A Retrospective, Combined Semi-
Quantitative and Quantitative Assessment
Marina Padroni1, Andrea Bernardoni2, Carmine Tamborino1, Gloria Roversi1,
Massimo Borrelli3, Andrea Saletti3, Alessandro De Vito4, Cristiano Azzini4, Luca Borgatti3,
Onofrio Marcello3, Christopher d’Esterre5,6, Stefano Ceruti3, Ilaria Casetta1, Ting-
Yim Lee6,7, Enrico Fainardi3*
1 Section of Neurology, Department of Biological, Psychiatric and Psychological Science, University of
Ferrara, Ferrara, Italy, 2 Section of Diagnostic Imaging, Department of Morphology, Surgery and
Experimental Medicine, University of Ferrara, Ferrara, Italy, 3 Neuroradiology Unit, Department of
Neuroscience and Rehabilitation, Azienda Ospedaliera Universitaria, Ferrara, Italy, 4 Neurology Unit,
Department of Neuroscience and Rehabilitation, Azienda Ospedaliera Universitaria, Ferrara, Italy, 5 Calgary
Stroke Program, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada,
6 Imaging Research Lab, Robarts Research Institute, Western Ontario University, London, Ontario, Canada,
7 Imaging program, Lawson Health Research Institute, Western Ontario University, London, Ontario,
Canada
* henryfai@tin.it
Abstract
Introduction
The capability of CT perfusion (CTP) Alberta Stroke Program Early CT Score (ASPECTS)
to predict outcome and identify ischemia severity in acute ischemic stroke (AIS) patients is
still questioned.
Methods
62 patients with AIS were imaged within 8 hours of symptom onset by non-contrast CT, CT
angiography and CTP scans at admission and 24 hours. CTP ASPECTSwas calculated on
the affected hemisphere using cerebral blood flow (CBF), cerebral blood volume (CBV) and
mean transit time (MTT) maps by subtracting 1 point for any abnormalities visually detected or
measured within multiple cortical circular regions of interest according to previously established
thresholds. MTT-CBV ASPECTSwas considered as CTP ASPECTSmismatch. Hemorrhagic
transformation (HT), recanalization status and reperfusion grade at 24 hours, final infarct vol-
ume at 7 days andmodified Rankin scale (mRS) at 3 months after onset were recorded.
Results
Semi-quantitative and quantitative CTP ASPECTS were highly correlated (p<0.00001).
CBF, CBV and MTT ASPECTS were higher in patients with no HT and mRS2 and
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inversely associated with final infarct volume and mRS (p values: from p<0.05 to
p<0.00001). CTP ASPECTSmismatch was slightly associated with radiological and clinical
outcomes (p values: from p<0.05 to p<0.02) only if evaluated quantitatively. A CBV
ASPECTS of 9 was the optimal semi-quantitative value for predicting outcome.
Conclusions
Our findings suggest that visual inspection of CTP ASPECTS recognizes infarct and ische-
mic absolute values. Semi-quantitative CBV ASPECTS, but not CTP ASPECTS mismatch,
represents a strong prognostic indicator, implying that core extent is the main determinant
of outcome, irrespective of penumbra size.
Introduction
Acute ischemic stroke (AIS) can be effectively treated with reperfusion therapies, such as intra-
venous fibrinolysis with recombinant tissue-plasminogen activator (t-PA) and mechanical
thrombectomy, which improve clinical outcome [1]. Moreover, the selection of patients with
AIS for reperfusion therapies is presently suboptimal as many patients do not achieve a good
clinical outcome, despite successful recanalization [2]. This is largely due to the constraints of
neuroimaging techniques which are unable to accurately identify patients who could benefit
from such therapies [3]. In fact, non-contrast CT (NCCT) using the Alberta Stroke Program
Early CT Score (ASPECTS) to detect early ischemic signs in the middle cerebral artery (MCA)
territory is still considered the method of choice for the selection of patients eligible for reperfu-
sion therapies [4]. However, while ASPECTS prognostic value has been questioned, ASPECTS
does not yield the extent of ischemic penumbra and its inter-observer agreement is modest [5].
Using a threshold-based paradigm, CT perfusion (CTP) has the potential to discriminate
between irreversibly damaged tissue, the infarct core (the area with low CBV and low CBF but
high MTT), and tissue at risk of infarction, the ischemic penumbra (the area with normal CBV
and low CBF but high MTT) [6,7]. Given that AIS patients receiving treatment according to
this penumbral hypothesis were shown to have a good prognosis, it suggests a possible role for
CTP in the selection of patients for reperfusion therapies [3]. Unfortunately, these results were
not confirmed by previous clinical trials based on penumbral selection in that a favorable CTP
penumbra profile was not significantly associated with a better outcome [8,9]. The demonstra-
tion that CBF better approximates the extent of the infarct core than CBV could be the expla-
nation for these negative findings [10]. In addition, this new approach was successfully used
for patient selection for endovascular treatment in two recent clinical trials [11,12]. In this con-
text, the application of ASPECTS methodology to CTP maps could be useful to overcome the
limitations of threshold-derived CTP penumbral maps based on MTT/CBV mismatch model
because it has been proven that CTP ASPECTS has a strong correlation with outcome [13–17],
a prognostic value greater than NCCT ASPECTS [13–15] and a good interobserver agreement
[18]. Furthermore, although previous publications indicate that CBV ASPECTS is the best
predictor of prognosis, the optimal threshold to discriminate between AIS patients with good
and poor clinical outcome ranges from 6 to 9 [13–17]. Finally, the accuracy of visual CTP
ASPECTS abnormalities in properly identifying the severity of ischemia remain to be
understood. In particular, it is still unclear whether CBV and CBF or MTT ASPECTS
defects correspond to their respective absolute and relative values which are currently pre-
sumed to be indicative of infarct core and total hypoperfusion, respectively [6,7]. In light of
CTP ASPECTS Prognostic Value in AIS
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these considerations, the objective of this retrospective study was two-fold: to clarify the prog-
nostic relevance of CTP ASPECTS and to determine whether CTP ASPECTS is able to recog-
nize the severity of hypoperfusion, as compared with quantitative measurements.
Materials and Methods
Ethics statement
The study was approved by the Research Ethics Board of Azienda Ospedaliero-Universitaria di
Ferrara (Italy). Written informed consent was obtained from each patient or from the patient’s
legal representative at admission.
Patient selection and study design
At our Institution, all patients presenting with suspected anterior circulation AIS and no his-
tory of renal failure or contrast allergy routinely undergo NCCT, CT angiography (CTA) of the
cervical and intracranial vessels and CTP at admission if they arrive at the hospital within 8
hours of symptom onset. If diagnosis of AIS is confirmed by neuroimaging findings, NCCT,
CTA and CTP are repeated at 24 hours to determine initial infarct size, degree of recanalization
and extent of reperfusion, respectively, and an additional NCCT is performed at 7 days to
determine the final infarct volume. If appropriate, according to the current recommended
guidelines [1], AIS patients receive intravenous fibrinolysis with t-PA or endovascular treat-
ment when stroke onset is<4.5 hours or between 4.5–8 hours, respectively. We retrospectively
reviewed the clinical and radiological data of 109 consecutively screened potentially eligible
AIS patients admitted to the Neuroscience Department of Ferrara during the period from
October 2008 to October 2010. This time period was chosen in order to analyze only patients
with one-phase CTP acquisition protocol, thus allowing a comparison with previous studies
[13–17]. Inclusion criteria were: 1) presentation at the hospital within 8 hours from symptom
onset; 2) baseline and follow-up confirmation of hemispheric AIS; 3) baseline and follow-up
CT imaging carried out at the established time-points after symptom onset (NCCT, CTA and
CTP at admission, NCCT, CTA and CTP at 24 hours and NCCT at 7 days); 4) CTP performed
with a one-phase acquisition protocol. Exclusion criteria were: 1) detection of intracerebral
hemorrhage at admission NCCT; 2) inability to complete multimodal CT protocol at baseline
and follow-up; 3) evidence of lacunar or brain stem infarct; 4) previous strokes with residual
deficit; 5) contraindications to iodinated contrast agent; 6) pregnancy; 7) age<18 years; 8) clin-
ical instability and/or poor quality of CT acquisition due to motion artifacts. Overall, 62
patients with clinical diagnosis of AIS met the previously mentioned inclusion criteria and
were included for the study (Fig 1).
Clinical assessment
Type of reperfusion therapy (if any) was also collected. Stroke subtypes were classified accord-
ing to Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria. Disease severity at
onset, at 24 hours and at 7 days at 3 months after stroke was scored using the National
Institutes of Health Stroke Scale (NIHSS). Clinical outcome was measured by the modified
Rankin scale (mRS) at 3 months. mRS2 and>2 were defined as good and poor outcomes,
respectively.
Imaging acquisition protocol
All imaging was conducted on a 64-slice Lightspeed VCT scanner (GE Healthcare, Waukesha,
WI, USA). NCCT helical scans were performed from the skull base to the vertex using the
CTP ASPECTS Prognostic Value in AIS
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following imaging parameters: 120 kV, 340 mA, 4x5-mm collimation, 1 second/rotation, and
table speed of 15 mm/rotation. CTA was performed as follows: 0.7 mL/kg contrast (maximum
90 mL), 5- to 10-second delay from injection to scanning, 120 kV, 270 mA, 1 second/rotation,
1.25-mm thick slices, and table speed 3.75 mm/rotation. CTA covered from the carotid bifurca-
tion to vertex. CTP studies were performed at admission with a dynamic first-pass bolus-track-
ing methodology according to a one-phase imaging protocol consisting of an acquisition of
50-seconds continuous (cine) scans reconstructed with a 25 cm field-of-view at 0.5 second
intervals to produce a series of 99 sequential images for each of eight 5 mm thick sections (792
images; matrix size = 512 × 512) which covered a total of 4 cm from the basal ganglia to the lat-
eral ventricles. The other parameters of the cine scan were 80 kV, 100 mA and 0.5 rotation
time. The cine scan was initiated 5 seconds after the automatic injection (Medrad, Indianola,
PA) of 40 ml of non-ionic contrast agent (Iomeron 300 mg/ml, Bracco Imaging SpA) at the
rate of 4 ml/sec into an antecubital vein.
Fig 1. Inclusion and exclusion flow chart of the study.
doi:10.1371/journal.pone.0147910.g001
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Imaging processing and analysis
The extension of early ischemic changes (hypoattenuation, loss of the gray-white matter
boundary and effacement of cortical sulci) was evaluated on NCCT at onset by ASPECTS
methodology, a 10-point ordinal scale that rates the presence or absence of ischemia in 10
regions included in the middle cerebral artery territory assigning a score of 1 for normal and 0
for a region showing early ischemic signs [4]. According to EXTEND-IA trial [11], the severity
of arterial occlusion was judged on CTA at onset using a modified version of the Thrombolysis
in Myocardial Infarction (TIMI) grading system [19]: complete occlusion (TIMI score = 0–1);
partial occlusion (TIMI score = 2); no occlusion (TIMI score = 3). Patients were categorized as
occluded if TIMI score was between 0 and 1 or not occluded when TIMI score was between 2
and 3. In occluded patients, the site of occlusion was assessed as indicated before [20]. All CTP
scans were assessed using a commercially available delay-sensitive deconvolution software (CT
Perfusion 3, GE Healthcare, Waukesha, WI). For each CTP scan, time-density curves (TDC)
for the arterial input function (AIF) and venous output functions (VOF) were obtained from
the anterior cerebral artery and superior sagittal sinus, respectively. The AIF was corrected for
partial volume averaging using the VOF-TDC. CBF, CBV and MTT CTP maps were generated
for each patient by deconvolution of tissue TDCs and the AIF. CBF, CBV and MTT values
were expressed in mlmin-1(100g)-1, ml(100g)-1and seconds, respectively. Average CTP maps
were created by averaging the cine CTP images over the duration of the first pass of contrast.
These average CTP images were used to exclude cerebrospinal fluid and cranium from analysis.
Large blood vessels were automatically excluded from calculation by the software. Color coded
functional CTP map scales were set at 0–100 mlmin-1(100g)-1 for CBF, 0–8 ml(100g)-1 for
CBV and 0–20 seconds for MTT. The side of the hypoperfused arterial territory, as visually
detected on MTT maps at admission, was indicated for each patient. ASPECTS was semi-quan-
titatively and quantitatively calculated using CBF, CBV and MTT CTP maps. As described
elsewhere [13–17], semi-quantitative analysis was performed by applying ASPECTS and allot-
ting a score of 1 for normal and 0 for abnormal perfusion regions. Specifically, we subtracted 1
point for each affected area, specified by ASPECTS methodology [4], where CBF, CBV or MTT
defects were visually detected. As shown in Fig 2, quantitative assessment was carried out by
measuring CTP values within multiple circular regions of interest (ROIs) larger than 1 cm2 and
manually drawn on the baseline source and averaged CTP images on all specified regions of
the two ASPECTS levels in the ischemic hemisphere. ROI’s were then automatically reflected
about the midline to obtain homologous ROIs in the contralateral hemisphere. All these ROIs
were automatically superimposed on CBF, CBV and MTT colour maps. One point was sub-
tracted for each ROI with abnormal CBF, CBV and MTT levels according to the previously
established thresholds: CBF24.6 mlmin-1(100g)-1; CBV1.1 ml(100g)-1; MTT>145% of
contralateral side [6,7]. As MTT and CBV maps were used to define total hypoperfusion and
infarct core, respectively, CTP ASPECTS mismatch was considered as the CBV ASPECTS
minus the MTT ASPECTS in both semi-quantative and quantitative analyses [21]. Final infarct
volume was measured on follow-up NCCT at 7 days after symptom onset with a multi-slice
planimetric method by summation of the hypodense areas, manually traced on each slice in
which they were detectable, multiplied by slice thickness. As previously described [22], swelling
extending across midline or producing ventricular effacement were excluded from calculation
to reduce early subacute vasogenic edema effects. The type of HT was classified on NCCT at 24
hours and at 7 days post ictus according to the European Cooperative Acute Stroke Study
(ECASS)-II criteria [23] into four different categories: hemorrhagic infarction type 1 (HI-1),
HI type 2 (HI-2), Parenchymal hemorrhage type 1 (PH-1), and PH type 2 (PH-2). In agree-
ment with EXTEND-IA trial [11], recanalization was scored on CTA at 24 hours with an
CTP ASPECTS Prognostic Value in AIS
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adaptation of the TIMI grading system [19]: persistent occlusion (TIMI score = 0–1); partial
recanalization (TIMI score = 2); full recanalization (TIMI score = 3). Patients with TIMI score
ranging from 2 to 3 were considered as recanalized, whereas patients with TIMI score of 0 and
1 were classified as not recanalized. All patients not occluded on CTA at admission had a TIMI
score of 3 at 24 hour-CTA and therefore, were considered as recanalized. As only 9 patients
underwent endovascular procedures, recanalization status was established using CTA at 24
hours also in these subjects to make data collection from our study population more homoge-
neous. Reperfusion was evaluated by reperfusion index that measures the percentage reduction
of baseline MTT lesion at 24 hours [24]. For this purpose, visually identified MTT defect vol-
ume was obtained by a manual multi-slice planimetric method at admission and at 24 hours.
Patients with a reperfusion index>75% were considered as reperfused.
Statistical analysis
The normality of each variable was checked by using the Kolmogorov-Smirnov test and
parametric or non- parametric tests were used accordingly. Continuous variables were com-
pared by independent-sample t test or Mann-Whitney U test, whereas their correlations were
assessed by linear regression or Spearman's rank correlation coefficient, respectively. Receiver
Operating Characteristic (ROC) curves were used to determine semi-quantitative and quanti-
tative CTP ASPECTS cut-off points which optimally discriminated between good and poor
outcome. A value of p<0.05 was accepted as statistically significant.
Results
Clinical and radiological findings
Demographic, clinical and radiological data recorded in our AIS patients are listed in Table 1.
In our study population, 37/62 (59.7%) patients were treated (28 with intravenous
Fig 2. Non-constrast CT, baseline source and average CT perfusion images, cerebral blood flow (CBF), cerebral blood volume (CBV) andmean transit
time (MTT) maps at ganglionic (A-F) and supraganglionic (G-L) axial ASPECTS levels.Multiple circular regions of interest (ROIs) larger than 1 cm2 placed
freehand in the affected hemisphere and automatically reflected into homologous regions of the contralateral hemisphere were used to measure CBF, CBV and
MTT absolute values from the corresponding functional maps in ASPECTS regions at ganglionic (anterior middle cerebral artery cortex, middle cerebral artery
cortex lateral to insular ribbon, posterior middle cerebral artery cortex, insula, caudate nucleus, lentiform nucleus and internal capsule) and supraganglionic
(anterior, lateral, and posterior middle cerebral artery cortical territories immediately superior to the previous ones, rostral to basal ganglia) sections.
doi:10.1371/journal.pone.0147910.g002
CTP ASPECTS Prognostic Value in AIS
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thrombolysis with r-tPA, 3 with intra-arterial thrombolysis and 6 with mechanical
thrombectomy), whereas 25/62 (40.3%) did not receive any therapy due to the presence of
hypodensity>1/3 cerebral hemisphere, as indicated by ASPECTS7, on admission NCCT
(n = 19), the occurrence of severe stroke, as showed by a NIHSS>25 (n = 4) at presentation
and the current use of anticoagulant with INR>1.7 (n = 2). A good outcome (mRS2) was
achieved in 42/62 (67.7%) cases, whereas a poor outcome (mRS>2) was present in 20/62
Table 1. Demographic, clinical and radiological characteristics in 62 patients with acute ischemic
stroke.
Sex: Female/Male 32/30
Age, years: mean±SD 68.1±11.6
TOAST:
Atherotrombotic 30/62 (48.4%)
Cardioembolic 28/62 (45.2%)
Undetermined 4/62 (6.4%)
NIHSS at entry: median, IQR, mean±SD, range 11, 8–17, 12.5±6.9,
1–28
NIHSS at 24 hours: median, IQR, mean±SD, range 8, 3–13, 9.1±6.9, 0–26
NIHSS at 7 days: median, IQR, mean±SD, range 4, 1–11, 6.9±6.9, 0–25
mRS at 3 months: median, IQR, mean±SD, range 1, 1–3, 2.0±1.6, 0–6
Time between symptom onset and CT scan at admission (hours): median, IQR,
mean ± SD, range
2, 1.3–4.0, 2.8±2.1,
0.4–7.5
Time window at admission: n/total (%)
< 4.5 hours 48/62 (77.4%)
4.5–8 hours 14/62 (22.6%)
NCCT ASPECTS at admission: median, IQR, mean±SD, range 9, 7–10, 8.5±1.6, 4–10
Occlusion grade on CTA at admission: n/total (%)
Occluded 45/62 (72.6%)
Not occluded 17/62 (27.4%)
Occlusion location on CTA at admission: n/total (%)
Proximal MCA-M1 7/62 (11.3%)
Distal MCA-M1 12/62 (19.4%)
MCA-M2 19/62 (30.6%)
Proximal ICA 4/62 (6.5%)
T occlusion 3/62 (4.8%)
Involved arterial territory on CTP at admission: n/total (%)
Right MCA 39/62 (62.9%)
Left MCA 23/62 (37.1%)
Time between symptom onset and CT scan at 24 hours (hours): median, IQR,
mean±SD, range
23, 20–24, 21.6± 3.1,
12–24
Time between CT scan at admission and at 24 hours (hours): median, IQR,
mean±SD, range
24, 22–24, 22.0±2.0,
17–24
Time between symptom onset and CT scan at 7 days (days): median, IQR,
mean±SD, range
6, 6–7, 6.3±0.9, 5–9
Final infarct volume (ml) on NCCT at 7 day: median, IQR, mean±SD, range 24, 7–54, 44.5±56,2,
0–245
SD = Standard deviation; TOAST = Trial of ORG 10172 in Acute Stroke Treatment; NIHSS = National
Institutes of Health Stroke Scale; IQR = Interquartile range; mRS = modified Rankin Scale: NCCT = non-
contrast CT; CTA = CT angiography; MCA = middle cerebral artery; ICA = Internal carotid artery: CTP = CT
perfusion.
doi:10.1371/journal.pone.0147910.t001
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(32.3%) patients. HT was observed in 27/62 (43.5%) patients (22 HI and 5 PH) appearing at
24 hours (n = 8) and at 7 days (n = 19) after stroke onset. At twenty-four hour post ictus, 45/62
(72.6%) achieved recanalization while 17/62 (27.4%) did not, 25/62 (40.3%) were reperfused
and 37/62 (59.7%) not reperfused.
Relationship between semi-quantitative and quantitative ASPECTS
Median semi-quantitative ASPECTS was 5 (IQR = 3–7; mean±SD = 4.9±2.7; range = 0–9) for
CBF maps, 9 (IQR = 7–10; mean±SD = 8.3±2.7; range = 3–10) for CBV and 5 (IQR = 3–7;
mean±SD = 5.0±2.7; range = 0–9) for MTT. Median semi-quantitative ASPECTS mismatch
was 3 (IQR = 2–5; mean±SD = 3.3±2.1; range = 0–8). Median quantitative ASPECTS was
5.5 (IQR = 3.3–7; mean±SD = 5.0±3.0; range = 0–10) for CBF maps, 10 (IQR 9–10; mean±
SD = 8.9±1.6; range = 4–10) for CBV and 3 (IQR = 1.3–6; mean±SD = 3.7±2.9; range = 0–9)
for MTT. Median quantitative ASPECTS mismatch was 5 (IQR = 3–8; mean±SD = 5.2±2.7;
range = 0–10). There were no differences between semi-quantitative and quantitative CBF and
CBV ASPECTS, whereas ASPECTS was greater for semi-quantitative than for quantitative
MTT (p<0.02) and for quantitative than for semi-quantitative mismatch (p<0.0001) (Fig 3).
As illustrated in Fig 4, semi-quantitative and quantitative CBF, CBV, MTT ASPECTS and CTP
ASPECTS mismatch were highly correlated (p<0.00001).
Relationship between semi-quantitative and quantitative ASPECTS and
clinical and radiological features
As reported in Table 2, AIS patients with no HT had higher values compared with those with
HT for semi-quantitative and quantitative CBF (p<0.0001), CBV (p<0.00001 and p<0.001,
respectively) and MTT (p<0.001 and p<0.0001, respectively) ASPECTS. On the contrary,
while semi-quantitative CTP ASPECTS mismatch was similar in AIS patients with and without
HT, quantitative CTP ASPECTS mismatch was more elevated in AIS patients with no HT than
in those with HT (p<0.05). Semi-quantitative and quantitative ASPECTS were greater in AIS
patients with good outcome than in those with poor outcome for CBF (p<0.01 and p<0.001,
respectively), CBV (p<0.01 and p<0.05, respectively) and MTT (p<0.02 and p<0.001, respec-
tively). No differences were found between AIS patients with mRS2 and mRS>2 for semi-
quantitative CTP ASPECTS mismatch, whereas AIS patients with good outcome had more ele-
vated quantitative CTP ASPECTS mismatch compared to those with poor outcome (p<0.02).
Tables 3 and 4 show the correlations we found between semi-quantitative and quantitative
CTP ASPECTS and radiological and clinical outcome measures respectively. An inverse associ-
ation was observed between semi-quantitative and quantitative CBF, CBV and MTT ASPECTS
and final infarct volume (p<0.00001) as well as between mRS and semi-quantitative and quan-
titative ASPECTS for CBF (p<0.01 and p<0.0001, respectively), CBV (p<0.001 and p<0.0001,
respectively) and MTT (p<0.02 and p<0.0001, respectively). No relationships were detected
between semi-quantitative CTP ASPECTS mismatch and final infarct volume and mRS,
whereas quantitative CTP ASPECTS was positively but only modestly correlated with both
final infarct volume and clinical outcome (p<0.02 and 0.05, respectively). After categorization
of AIS patients according to recanalization status, a negative association was observed between
final infarct volume and semi-quantitative and quantitative CBF (p<0.001 and p< 0.01,
respectively), CBV (p<0.00001) and MTT (p<0.01 and p<0.001, respectively) ASPECTS, and
between clinical outcome and qualitative MTT ASPECTS and CTP mismatch (p<0.01) in
recanalized patients. No further relationships were seen between CTP ASPECTS and final
infarct volume and clinical outcome in recanalized and not recanalized patients. When AIS
patients were stratified according to reperfusion status, an inverse correlation was found
CTP ASPECTS Prognostic Value in AIS
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between final infarct volume and semi-quantitative CBF (p<0.01), semi-quantitative and
quantitative CBV (p<0.02 and p<0.01, respectively) and MTT (p<0.02) ASPECTS in reper-
fused patients and between final infarct volume and semi-quantitative and quantitative CBF
(p<0.01), CBV (p<0.000001 and p<0.0001, respectively) and MTT (p<0.05 and p<0.01,
respectively) ASPECTS in not reperfused patients. mRS was negatively associated with semi-
quantitative and quantitative CBF (p<0.02 and p<0.01, respectively) and CBV (p<0.01) and
quantitative MTT (p<0.02) ASPECTS only in not reperfused patients. There were no addi-
tional relationships between CTP ASPECTS and final infarct volume and clinical outcome in
reperfused and not reperfused patients.
Fig 3. Comparison between semi-quantitative (white boxes) and quantitative (grey boxes) ASPECTS for cerebral blood flow (CBF), cerebral blood
volume (CBV), mean transit time (MTT) and CT perfusion (CTP) mismatch. The boundaries of the box represent the 25th-75th quartile. The line within
the box indicates the median. The whiskers above and below the box correspond to the highest and lowest values, excluding outliers.
doi:10.1371/journal.pone.0147910.g003
CTP ASPECTS Prognostic Value in AIS
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Semi-quantitative and quantitative ASPECTS optimal values
As reported in Table 5, the optimal cut-off point for predicting favorable outcome was 6 for
CBF, 9 for CBV, 6 for MTT and 4 for CTP mismatch in semi-quantitative ASPECTS analysis
and 6 for CBF, 9 for CBV, 3 for MTT and 6 for CTP mismatch in quantitative evaluation. CBV
ASPECTS at a threshold value of 9 and MTT ASPECTS at a threshold value of 3 were the most
accurate parameters to identify good outcome in semi-quantitative and quantitative evalua-
tions, respectively, because they are the CTP ASPECTS scores that gave the best combination
of sensitivity and specificity in our patient population.
Discussion
In this study, we investigated the prognostic ability and the consistency of semi-quantitative
CTP ASPECTS in AIS using a concomitant quantitative method. This is the first time that
qualitative and threshold-based quantitative assessments of ASPECTS on CTP maps were
Fig 4. Relationships between semi-quantitative (y-axis) and quantitative (x-axis) ASPECTS for cerebral blood flow (CBF) (panel A), cerebral blood
volume (CBV) (panel B), mean transit time (MTT) (panel C) and CT perfusion (CTP) mismatch (panel D).
doi:10.1371/journal.pone.0147910.g004
CTP ASPECTS Prognostic Value in AIS
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Table 2. Semi-quantitative and quantitative CT perfusion (CTP) Alberta Stroke Program Early CT Score (ASPECTS) in 62 acute ischemic stroke
patients categorized according to hemorrhagic transformation (HT) and clinical outcome.
HT (n = 27) no HT (n = 35) p value mRS2 (n = 42) mRS>2 (n = 20) p value
Semi-quantitative CTP ASPECTS
CBF (median, IQR, mean ± SD, range) 3, 1.5–4.5, 6.1
±2.2, 2–9
6, 4.5–8, 3.3±2.4,
0–9
p<0.0001* 6, 3–8, 5.6±2.7,
0–9
4, 2–5, 3.5±2.2,
0–8
p<0.01*
CBV (median, IQR, mean ± SD, range) 7, 6–9, 7.2±1.8,
3–10
9, 9–10, 9.2±1.0,
6–10
p<0.00001^ 9, 9–10, 8.8±1.4,
6–10
8, 6–8, 7.3±1.9,
3–10
p<0.01^
MTT (median, IQR, mean ± SD, range) 3, 2–5, 3.6±2.5,
0–9
6, 4–8, 6.0±2.4,
2–9
p<0.001* 6, 3–8, 5.6±2.7,
0–9
4, 2–5, 3.8±2.3,
0–8
p<0.02*
CTP mismatch (median, IQR,
mean ± SD, range)
4, 2–5, 3.6±2.0,
0–7
3, 1–5, 3.2±2.3,
0–8
p = 0.488* 1, 1–1, 1.0±0.5,
0–2
4, 2–5, 3.5±2.0,
0–6
p = 0.686*
Quantitative CTP ASPECTS
CBF (median, IQR, mean ± SD, range) 4, 2–6, 3.9±2.6,
0–9
7, 5–8, 6.5±2.2,
2–10
p<0.0001* 7, 4–8, 6.1±2.5,
1–10
4, 2–5, 3.8±2.4,
0–8
p<0.001*
CBV (median, IQR, mean ± SD, range) 9, 7–9.5, 8.1±1.9,
4–10
10, 10–10, 9.6
±0.9,6–10
p<0.001^ 10, 9–10, 9.3±1.1,
6–10
9, 7–10, 8.1
±2.1,4–10
p = 0.021^
MTT (median, IQR, mean ± SD, range) 1, 0–3, 2.0±2.5,
0–9
6, 3–7, 5.1±2.5,
0–9
p<0.0001* 5, 2–7, 4.7±3.0,
0–9
2, 0–2, 1.7±1.7,
0–6
p<0.001*
CTP mismatch (median, IQR,
mean ± SD, range)
6, 4–8, 6.1±2.6,
0–10
4, 2,5–7, 4.5
±2.6,0–10
p = 0.021* 1, 1–1, 1.0±0.5,
0–2
7, 5–8, 6.4±1.9,
4–10
p<0.02*
CBF = cerebral blood flow; CBV = cerebral blood volume; MTT = mean transit time; SD = Standard deviation; IQR = Interquartile range; mRS  2 = good
outcome; mRS > 2 = poor outcome
statistical analysis = *t-test
^Mann-Whitney.
doi:10.1371/journal.pone.0147910.t002
Table 3. Correlation between semi-quantitative and quantitative CT perfusion (CTP) Alberta Stroke Program Early CT Score (ASPECTS) and final
infarct volume as measured on NCCT at 7 days after symptom onset in 62 acute ischemic stroke patients considered as a whole (total patients)
and grouped according recanalization and reperfusion levels.
Total patients
(n = 62)
Recanalized (n = 45) not recanalized
(n = 17)
Reperfused (n = 25) not reperfused
(n = 37)
Semi-quantitative CTP
ASPECTS
CBF r = -0.582094;
p<0.00001
r = -0.500480;
p<0.001
r = -0.221318;
p = 0.393
r = -0.538078;
p<0.01
r = -0.438866; p<0.01
CBV r = -0.707869;
p<0.00001
r = -0.694085;
p<0.00001
r = -0.554911;
p = 0.021
r = -0.688623;
p<0.02
r = -0.682344;
p<0.000001
MTT r = -0.531381;
p<0.00001
r = -0.431643; p<0.01 r = -0.138321;
p = 0.597
r = -0.483270;
p<0.02
r = -0.349885;
p = 0.034
CTP mismatch r = 0.113193;
p = 0.381
r = 0.001801;
p = 0.991
r = -0.360055;
p = 0.156
r = 0.102910;
p = 0.624
r = -0.082973;
p = 0.625
Quantitative CTP ASPECTS
CBF r = -0.568907;
p<0.00001
r = -0.422621; p<0.01 r = -0.380731;
p = 0.132
r = -0.307668;
p = 0.135
r = -0.544224; p<0.001
CBV r = -0.566817;
p<0.00001
r = -0.621084;
p<0.00001
r = -0.543278;
p = 0.024
r = -0.506412;
p<0.01
r = -0.602951;
p<0.0001
MTT r = -0.641047;
p<0.00001
r = -0.532585;
p<0.001
r = -0.419322;
p = 0.094
r = -0.479297;
p<0.02
r = -0.470496; p<0.01
CTP mismatch r = 0.313840; p<0.02 r = 0.292660;
p = 0.051
r = -0.194174;
p = 0.455
r = 0.265259;
p = 0.200
r = 0.093855;
p = 0.581
CBF = cerebral blood flow; CBV = cerebral blood volume; MTT = mean transit time; statistical analysis = Spearman's rank correlation coefficient.
doi:10.1371/journal.pone.0147910.t003
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compared. In the past, these two techniques were always applied separately to calculate CTP
ASPECTS for predicting clinical outcome in AIS patients [13–17]. In addition, our investiga-
tion is the first to demonstrate that semi-quantitative CBF, CBV and MTT ASPECTS were
higher in AIS patients without HT than in those with HT. On the contrary, there were no dif-
ferences between HT and no HT in AIS patients for the semi-quantitative ASPECTS mismatch.
Table 4. Correlation between semi-quantitative and quantitative CT perfusion (CTP) Alberta Stroke Program Early CT Score (ASPECTS) and clini-
cal outcome asmeasured with modified Rankin scale (mRS) at 3 months in 62 acute ischemic stroke patients considered as a whole (total patients)
and grouped according recanalization and reperfusion levels.
Total patients
(n = 62)
Recanalized
(n = 45)
not recanalized (n = 17) Reperfused
(n = 25)
not reperfused
(n = 37)
Semi-quantitative CTP
ASPECTS
CBF r = -0.329956;
p<0.01*
r = -0.263718;
p = 0.080*
r2 = -0.004; beta = -0.24;
p = 0.350^
r = -0.146;
p = 0.485*
r = -0.386; p<0.02*
CBV r = -0.424394;
p<0.001*
r = -0.293664;
p = 0.050*
r2 = -0.233503; beta = -0.53;
p = 0.029^
r = -0.037;
p = 0.859*
r = -0.572; p<0.01*
MTT r = -0.301226;
p<0.02*
r = -0.204617;
p = 0.178*
r2 = -0.019; beta = -0.21;
p = 0.416^
r = -0.136;
p = 0.518*
r = -0.308;
p = 0.064*
CTP mismatch r = 0.065819;
p = 0.611*
r = -0.022279;
p = 0.885*
r2 = -0.061; beta = -0.35;
p = 0.175^
r = -0.032;
p = 0.879*
r = -0.071;
p = 0.0678*
Quantitative CTP
ASPECTS
CBF r = -0.540281;
p<0.00001*
r = -0.240467;
p = 0.112*
r2 = -0.056; beta = -0.34;
p = 0.183*
r = -0.101;
p = 0.632*
r = -0.445; p<0.01*
CBV r = -0.609260;
p<0.00001*
r = -0.190077;
p = 0.211*
r2 = -0.214; beta = -0.51;
p = 0.035^
r = -0.016;
p = 0.941*
r = -0.487; p<0.01*
MTT r = -0.599370;
p<0.00001*
r = -0.381008;
p<0.01*
r2 = -0.090; beta = -0.38;
p = 0.130^
r = -0.297;
p = 0.149*
r = -0.407; p<0.02*
CTP mismatch r = 0.287592;
p = 0.023*
r = -0.381008;
p<0.01*
r2 = -0.047; beta = -0.14;
p = 0.604^
r = -0.275;
p = 0.183*
r = -0.074;
p = 0.665*
CBF = cerebral blood flow; CBV = cerebral blood volume; MTT = mean transit time
statistical analysis = *Spearman's rank correlation coefficient
^Linear regression.
doi:10.1371/journal.pone.0147910.t004
Table 5. Semi-quantitative and quantitative CT perfusion (CTP) Alberta Stroke Program Early CT Score (ASPECTS) optimal values for recognizing
AIS patients with good clinical outcome (mRS<2 at 3 months) as calculated using Receiver Operating Characteristic (ROC) curves.
Cut-off values Sensitivity Specificity AUC
Semi-quantitative CTP ASPECTS
CBF 6 57.1% 80% 0.724
CBV 9 78.6% 75% 0.749
MTT 6 52.4% 75% 0.693
CTP mismatch 4 40.5% 45% 0.455
Quantitative CTP ASPECTS
CBF 6 61.9% 75% 0.754
CBV 9 83.3% 40% 0.682
MTT 3 73.8% 80% 0.793
CTP mismatch 6 38.1% 40% 0.305
mRS = modified Rankin scale; CBF = cerebral blood flow; CBV = cerebral blood volume; MTT = mean transit time; AUC = area under the curve.
doi:10.1371/journal.pone.0147910.t005
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These findings are in agreement with previous studies documenting that the risk of developing
HT is associated not only to low values of CBV [25], but also to reduced levels of CBF and ele-
vated values of MTT [26], and suggest that HT is related to an impairment of the blood-brain
barrier promoted by the severity of ischemia, irrespective of the extent of the ischemic penum-
bra. More importantly, consistent with previously published data [13–17], we proved that
semi-quantitative CBF, CBV and MTT ASPECTS were robust predictors of final infarct vol-
ume and clinical outcome. In fact, they were greater in patients with mRS2 than in those with
mRS>2 and their high values were strongly correlated with a small final infarct volume and a
favorable clinical outcome. Surprisingly, the semi-quantitative CTP ASPECTS mismatch did
not show any association with radiological and clinical outcomes, indicating that the extent of
the ischemic penumbra does not seem to be related to the prognosis. These results are discor-
dant with those coming from previous works [15,16], probably due to differences in ASPECTS
determination techniques and patient selection. The poor relationship between semi-quantita-
tive CTP ASPECTS mismatch and outcome was confirmed after the classification of patients
according to recanalization and reperfusion grades. Moreover, this categorization provided fur-
ther controversial findings which can explain why the predictive power of semi-quantitative
CTP ASPECTS with respect to infarct volume and clinical outcome deteriorated after the strat-
ification of AIS patients according to recanalization and reperfusion statuses. As expected,
semi-quantitative CBF, CBV and MTT ASPECTS were inversely correlated with final infarct
volume and clinical outcome in recanalized but not in not recanalized patients. Conversely,
they showed a negative correlation with final infarct size not only in reperfused but also in not
reperfused patients. In addition, an inverse association between semi-quantitative CBF and
CBV ASPECTS and mRS2 was observed only in not reperfused patients. Therefore, although
reperfusion is currently considered a prognostic indicator stronger than recanalization [27],
our results suggest that a favorable CTP ASPECTS leads to a good radiological outcome in
recanalized patients regardless of reperfusion status, but it is associated with a good clinical
outcome only in recanalized and not reperfused patients. This implies that, in some cases,
reperfusion may be futile inducing a luxury perfusion, exceeding metabolic demand, in non-
viable tissue evolving into infarct [28]. Furthermore, we found that CBV ASPECTS with a cut-
off point of 9 was the best semi-quantitative parameter for differentiating between good and
poor outcome. This threshold level is in contrast with most prior publications where the opti-
mal value for CBV ASPECTS was>6 [13],7 [15],>7 [16] or8 [14], but it is concordant
with a recent paper [17] in which a CBV ASPECTS of 9 was the most accurate for predicting
prognosis in a group of AIS patients receiving endovascular treatment. Interestingly, the quan-
titative analysis performed in our study confirmed that the optimal threshold for CBV
ASPECTS was 9, indicating that this threshold could be consistent in identifying favorable
prognosis and improving the selection of patients for reperfusion therapies. Of note, this high
CBV ASPECTS cut-off value could be affected by the presence of spontaneous recanalization
and partial reversibility of CBV lesion. In fact, it has recently demonstrated that CBV
ASPECTS can overestimate final infarct size in patients with spontaneous recanalization that
occurred in our population given the greater proportion of not treated with respect to not
recanalized patients [29]. On the other hand, it has lately been shown that admission CBV vol-
ume can be underestimated after early recanalization [29], likely in relation to the appearance
of hypervolemia that have the potential to mask infarct tissue [30]. However, our more
significant finding is the demonstration that there was a substantial agreement between semi-
quantitative and quantitative CTP ASPECTS, which were highly correlated and provided com-
parable results as indicators of radiological and clinical outcomes. Such data could have impor-
tant practical implications because they show that visual inspection is a fast, easy and reliable
tool to properly define the supposed infarct core (the CBV defect) and the presumed total
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hypoperfusion (the CBF or MTT defect). In addition, these results further strengthen the
hypothesis that the depth of ischemia rather than the extent of the penumbra is the main prog-
nostic determinant in AIS [31]. In fact, while quantitative MTT ASPECTS was the best predic-
tive parameters for clinical outcome, only a slight association was found between quantitative
CTP ASPECTS mismatch and radiological and clinical outcome measures. In this regard, the
inclusion of tissue not at risk for infarction (benign oligemia) in the quantitative assessment of
MTT maps represents a possible explanation for the lower MMT ASPECTS and the higher
CTP ASPECTS mismatch we obtained with quantitative analysis compared to visual assess-
ment. MTT thresholds employed in this study to identify total hypoperfusion were not suffi-
ciently restricted to exclude benign oligemia [32]. This study is affected by several limitations.
First, the small sample size and the retrospective nature of our investigation could weaken the
consistency of our data. Second, our CTP studies were performed with a delay-sensitive decon-
volution algorithm and one-phase acquisition protocol which lead to an incorrect estimation
of perfusion parameters due to the effects of bolus delay and truncation of time density curves,
respectively [30]. However, we chose this approach to be closest to clinical practice since the
majority of prior studies were carried-out with a similar protocol [13–17]. Third, the reliability
of our quantitative measurements could be questionable since it is well-known that different
commercial software programs provide different CTP absolute values [33]. For this reason, we
employed thresholds previously validated for one-phase acquisition protocol in our ROI analy-
sis [6,7]. Fourth, the use of the 7 day-NCCT to determine final infarction could lead to an over-
estimation of final infarct volume due to the development of an ongoing vasogenic edema in
early subacute phase. To overcome this possible drawback we had excluded swelling effects
from the measurements [22]. Fifth, as recanalization was established using the 24 hour CTA,
the exact recanalization time was not known. Finally, the actual impact of ischemic penumbra
on outcome remains to be elucidated because we did not use CBF to define infarct core and
Tmax to delineate total hypoperfusion, as recently recommended [10,11]. Nevertheless, it is
well known that the presence of leukoaraiosis often preclude a correct identification of ische-
mic core on visual interpretation of CBF maps [10]. In summary, our study showed that visual
assessment of CTP ASPECTS represents a good method to recognize the severity of ischemic
hypoperfusion and to predict HT and final infarct volume in AIS patients. CBV ASPECTS of 9
was a very stringent threshold value to identify favorable clinical outcome. Conversely, CTP
ASPECTS mismatch was a poor prognostic marker suggesting that the extent of ischemic pen-
umbra measured using CBV for delineating infarct core and MTT for defining total hypoperfu-
sion is not related to radiological and clinical outcomes. These findings indicate that size and
degree of ischemia as detected by semi-quantitative evaluation of CTP ASPECTS can be
used as fast and easily feasible prognostic indicators in AIS patients. Future studies in a larger
patient population are warranted to better understand the potential of semi-quantitative CTP
ASPECTS in improving the selection of AIS patients for reperfusion therapies.
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